IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating.<\/p>\n
Company:\u00a0\u00a0\u00a0\u00a0\u00a0 Medgenics, Inc.\u00a0\u00a0\u00a0<\/strong> Company:\u00a0\u00a0\u00a0\u00a0\u00a0 Paratek Pharmaceuticals\u00a0\u00a0\u00a0<\/strong> Company:\u00a0\u00a0\u00a0\u00a0\u00a0 Scynexis\u00a0\u00a0\u00a0<\/strong> Company:\u00a0\u00a0\u00a0\u00a0\u00a0 Communications Sales & Leasing, Inc.\u00a0\u00a0<\/strong> IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company:\u00a0\u00a0\u00a0\u00a0\u00a0 Medgenics, Inc.\u00a0\u00a0\u00a0 Symbol:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MDGN Price:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Last Trade $6.25 Description:\u00a0\u00a0 Re-offer Range: $5.50-$5.75 Trade Date:\u00a0\u00a0\u00a0 6\/21 Shares:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3.6 million Underwriter(s) Jefferies Co-Managers:\u00a0\u00a0[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[845,647,338,325],"class_list":["post-1333","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-csal","tag-mdgn","tag-prtk","tag-scyx"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1333"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1333\/revisions"}],"predecessor-version":[{"id":1334,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1333\/revisions\/1334"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nSymbol:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MDGN
\nPrice:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Last Trade $6.25
\nDescription:\u00a0\u00a0 Re-offer Range: $5.50-$5.75
\nTrade Date:\u00a0\u00a0\u00a0 6\/21
\nShares:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3.6 million
\nUnderwriter(s) Jefferies
\nCo-Managers:\u00a0\u00a0 N\/A
\nRating = Subscription Needed<\/p>\n
\nSymbol:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PRTK
\nPrice:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Last Trade $16.54
\nDescription:\u00a0 Re-offer Range:
\nTrade Date:\u00a0\u00a0 6\/22
\nShares:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3.75 million
\nUnderwriter(s) Leerink Partners, Guggenheim Securities
\nCo-Managers:\u00a0\u00a0 N\/A
\nRating = Subscription Needed<\/p>\n
\nSymbol:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SCYX
\nPrice:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Last Trade $2.65
\nDescription:\u00a0 No Re-Offer Available
\nTrade Date:\u00a0\u00a0\u00a0 6\/21
\nShares:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 TBD
\nUnderwriter(s) Guggenheim Securities
\nCo-Managers:\u00a0\u00a0 N\/A
\nRating = Subscription Needed<\/p>\n
\nSymbol:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CSAL
\nPrice:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Last Trade $28.16
\nDescription:\u00a0 Re-offer Range: $24.00-$26.00
\nTrade Date:\u00a0\u00a0\u00a0 6\/21
\nShares:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 14.7 million
\nUnderwriter(s) Citigroup, BofA Merrill Lynch, Barclays, Credit Suisse Securities, Goldman Sachs & Co., J.P. Morgan, Wells Fargo Securities
\nCo-Managers:\u00a0\u00a0 N\/A
\nRating = Subscription Needed<\/p>\n","protected":false},"excerpt":{"rendered":"